Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006
2011

Trends in Starting Diabetes Medications After Heart Attacks

Sample size: 66888 publication Evidence: high

Author Information

Author(s): Mette L Norgaard, Charlotte Andersson, Peter Riis Hansen, Søren S Andersen, Allan Vaag, Tina K Schramm, Fredrik Folke, Lars Køber, Christian Torp-Pedersen, Gunnar H Gislason

Primary Institution: Department of Cardiology, University Hospital of Copenhagen, Gentofte, Denmark

Hypothesis

The study aims to investigate temporal trends in the initiation of glucose-lowering medications among patients discharged after first-time myocardial infarction.

Conclusion

There was an increase in the initiation of glucose-lowering medications within the first year after a heart attack, indicating a growing awareness of diabetes management.

Supporting Evidence

  • 3962 patients initiated glucose-lowering medications during the study period.
  • An increase in incidence rates of GLM initiation in the MI population from 19.6 per 1000 person years in 1997 to approximately 27.6 in 2001 was demonstrated.
  • A similar trend was observed in the general population where the incidence rates increased from 2.8 in 1997 to 4.0 in 2004.

Takeaway

After a heart attack, more people are starting diabetes medications, which shows that doctors are becoming better at spotting diabetes in these patients.

Methodology

The study used nationwide registers to identify patients aged 30 and older who were hospitalized for first-time myocardial infarction and assessed the initiation of glucose-lowering medications through pharmacy prescriptions.

Potential Biases

There may be unmeasured confounders affecting the results.

Limitations

The study lacks information on additional factors influencing the decision for initiation of GLM and could not assess the duration of diabetes prior to initiation of GLM.

Participant Demographics

The study population comprised mostly males with a mean age of 68-69 years.

Statistical Information

P-Value

<0.0001

Confidence Interval

95% CI 1.20-1.67

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1475-2840-10-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication